UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000745
Receipt number R000000896
Scientific Title Phase I Radiation Dose Escalation Study using Four-dimensional Intensity Modulated Radiation Therapy for Locally Advanced Pancreatic Cancer
Date of disclosure of the study information 2007/06/21
Last modified on 2012/01/26 16:49:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase I Radiation Dose Escalation Study using Four-dimensional Intensity Modulated Radiation Therapy for Locally Advanced Pancreatic Cancer

Acronym

4DIMRT-PI for LA-Pancreatic Cancer

Scientific Title

Phase I Radiation Dose Escalation Study using Four-dimensional Intensity Modulated Radiation Therapy for Locally Advanced Pancreatic Cancer

Scientific Title:Acronym

4DIMRT-PI for LA-Pancreatic Cancer

Region

Japan


Condition

Condition

Locally advanced pancreatic cancer

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the safety and efficacy of 4D-IMRT with S-1 for locally advanced pancreatic cancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

Dose limiting toxicities
GI toxicities
Hematologic toxicities

Key secondary outcomes

Survival
Local control
Response rate
Time to develop metastases


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

Radiation dose escalation

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Written informed consent
2. Age <= 80 years old
3. KPS >= 70
4. No previous Tx for pancreatic cancer
5. Possible oral intake
6. No major systemic organ problem
7. UICC Stage III

Key exclusion criteria

1. Gastric pr duodenal ulcer
2. Use of phenitoin, walfalin potasium, flusitosin
3. Plural effusion, ascitis
4. Active infection
5. Major comorbidities
6. Congnitive deterioration
7. Allegy to drug
8. Pregnancy
9. If doctor judged not feasible to enroll

Target sample size

24


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hidefumi Aoyama

Organization

Hokkaido University Hospital

Division name

Radiology

Zip code


Address

North 14, West 5, Sapporo, Japan

TEL

011-706-5977

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hidefumi Aoyama

Organization

Hokkaido University Hospital

Division name

Radiology

Zip code


Address


TEL

011-716-1161

Homepage URL


Email



Sponsor or person

Institute

Hokkaido University Hospital
Dept. of Radiology
Dept. of Internal Medicine
Dept. of Medical Oncology
Dept. of Surgical Oncology

Institute

Department

Personal name



Funding Source

Organization

Not applicable

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 06 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 06 Month 13 Day

Date of IRB


Anticipated trial start date

2007 Year 06 Month 01 Day

Last follow-up date

2010 Year 03 Month 01 Day

Date of closure to data entry

2010 Year 03 Month 01 Day

Date trial data considered complete

2010 Year 03 Month 01 Day

Date analysis concluded

2010 Year 03 Month 01 Day


Other

Other related information



Management information

Registered date

2007 Year 06 Month 21 Day

Last modified on

2012 Year 01 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000896


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name